HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bisphosphonates induce breast cancer cell death in vitro.

Abstract
Breast cancer frequently spreads to bone and is almost always associated with osteolysis. This tumor-induced osteolysis is caused by increased osteoclastic bone resorption. Bisphosphonates are used successfully to inhibit bone resorption in tumor bone disease and may prevent development of new osteolytic lesions. The classical view is that bisphosphonates only act on bone cells. We investigated their effects on breast cancer cells using three human cell lines, namely, MCF-7, T47D, and MDA.MB.231, and we tested four structurally different bisphosphonates: clodronate, pamidronate, ibandronate, and zoledronate. We performed time course studies for each bisphosphonate at various concentrations and found that all four compounds induced a nonreversible growth inhibition in both MCF-7 and T47D cell lines in a time- and dose-dependent manner. The MDA.MB.231 cell line was less responsive. Bisphosphonates induced apoptosis in MCF-7 and cell necrosis in T47D cells. The inhibition of MCF-7 cell proliferation could be reverted almost completely by the benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethyl ketone (z-VAD-fmk) inhibitor of caspases, suggesting that the apoptotic process observed in the MCF-7 cell line is mediated, at least partly, by the caspase system. Caspase activity was little changed by bisphosphonates in T47D cells and the inhibitor of caspase did not modify bisphosphonates effects. In summary, we found that bisphosphonates inhibit breast cancer cell growth by inducing cell death in vitro. Such effects could contribute to the beneficial role of bisphosphonates in the treatment and the prevention of tumor-induced osteolysis.
AuthorsO Fromigue, L Lagneaux, J J Body
JournalJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (J Bone Miner Res) Vol. 15 Issue 11 Pg. 2211-21 (Nov 2000) ISSN: 0884-0431 [Print] United States
PMID11092402 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amino Acid Chloromethyl Ketones
  • Annexins
  • Antineoplastic Agents
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Diphosphonates
  • Imidazoles
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Clodronic Acid
  • Zoledronic Acid
  • Caspases
  • Pamidronate
  • Ibandronic Acid
Topics
  • Amino Acid Chloromethyl Ketones (pharmacology)
  • Annexins (metabolism)
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Breast Neoplasms (drug therapy, metabolism, pathology)
  • Caspase Inhibitors
  • Caspases (metabolism)
  • Cell Death (drug effects)
  • Cell Nucleus (drug effects)
  • Clodronic Acid (pharmacology)
  • Cysteine Proteinase Inhibitors (pharmacology)
  • Diphosphonates (pharmacology)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Ibandronic Acid
  • Imidazoles (pharmacology)
  • Kinetics
  • Pamidronate
  • Tumor Cells, Cultured
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: